Sanofi Teams With US Military On Zika, But Not For The Profits

Sanofi Pasteur has entered into an agreement with the US Walter Reed Army Institute of Research, part of the Department of Defense, to develop a Zika vaccine. But the company said it's not doing it for any potential profits, but has a "moral imperative" to respond to the epidemic.

SC1607_Zika_WalterReed-WRAIR_1200

It's never easy trying to convince the commercial side of a biopharmaceutical business why a company should go down the path of pursuing a product that may have great value in saving lives and preventing the spread of disease, but in the end, may not garner big profits.

That's what Jon Heinrichs, an associate vice president and segment head in global project leadership at Sanofi Pasteur's Swiftwater,...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip